Results 11 to 20 of about 275,119 (174)

Biomarcadores séricos para la evaluación de la fibrosis hepática [PDF]

open access: yesAdvances in Laboratory Medicine
La fibrosis hepática se desarrolla como respuesta a la presencia de daño hepático crónico de diferentes etiologías, provocando un desequilibrio entre la síntesis y degeneración de la matriz extracelular y la desregulación de diversos mecanismos ...
Maroto-García Julia   +4 more
doaj   +3 more sources

Regressão da fibrose hepática Regression of hepatic fibrosis

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2005
Durante muito tempo, se acreditou que a fibrose hepática extensa e de longa duração fosse um processo irreversível. As investigações sobre o comportamento da fibrose hepática, nas formas avançadas da esquistossomose, vieram abalar este conceito e hoje em
Zilton A. Andrade
doaj   +2 more sources

Liver and Spleen Stiffness as Non‐Invasive Tools Assessing Liver Congestion in Patients With Budd‐Chiari Syndrome [PDF]

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background and Aims Assessing liver congestion and portal hypertension (PHT) in Budd–Chiari syndrome (BCS) remains challenging. We evaluated liver and spleen stiffness measurements (LSM, SSM) obtained by transient elastography as non‐invasive tools for identifying clinically meaningful liver congestion in BCS.
Andreea Fodor   +22 more
wiley   +2 more sources

Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients [PDF]

open access: yes, 2021
Background Pseudomonas aeruginosa (PA) is an important respiratory pathogen for cystic fibrosis (CF) patients. Routine microbiology surveillance is time-consuming, and is best performed on expectorated sputum. As alternative, volatile organic compounds (
Davies, Jane   +16 more
core   +1 more source

Investigación de nuevas estrategias terapeúticas para la inflamación y la fibrosis hepática. [PDF]

open access: yes, 2010
[spa] La fibrosis hepática es el exceso de tejido conectivo fibroso en el hígado consecuencia de la inflamación crónica de éste. En estados muy avanzados (cirrosis) puede llevar consigo descompensaciones que pueden causar la muerte del paciente.
Moreno Sánchez, Montserrat
core   +8 more sources

Fibrosis hepática avanzada asociada a riesgo cardiovascular en adultos con enfermedad hepática grasa no alcohólica [PDF]

open access: yes, 2023
Determinar la asociación entre la fibrosis hepática avanzada y el riesgo cardiovascular en adultos con enfermedad hepática grasa no alcohólica. Material y Métodos: Se realizó un estudio analítico transversal, se recogieron los datos de historia ...
Solórzano Dragañac, Carlos José
core  

Lung Cancer in Pulmonary Fibrosis: Tales of Epithelial Cell Plasticity [PDF]

open access: yes, 2011
Lung epithelial cells exhibit a high degree of plasticity. Alterations to lung epithelial cell function are critically involved in several chronic lung diseases such as pulmonary fibrosis.
Königshoff, M.   +2 more
core   +1 more source

Non-invasive ventilation and clinical outcomes in cystic fibrosis: Findings from the UK CF registry [PDF]

open access: yes, 2018
Background: Non-invasive ventilation (NIV) for respiratory failure and airway clearance is an established intervention in cystic fibrosis (CF), but its therapeutic benefit on lung function and survival remains under-investigated. Methods: Using data from
Bilton, D   +5 more
core   +1 more source

MicroRNAs in fibrosis: opportunities and challenges [PDF]

open access: yes, 2016
MicroRNAs (miRNAs) are small, non-coding RNAs that mediate mRNA cleavage, translational repression or mRNA destabilisation and are around 22-25 nucleotides in length via partial complementary binding to the 3' untranslated region in target transcripts ...
O'Reilly, Steven, Steven O’Reilly
core   +1 more source

Frecuencia de fibrosis hepática avanzada en pacientes diabéticos con esteatosis hepática no alcohólica utilizando métodos no invasivos en un hospital general del tercer nivel en Lima - Perú [PDF]

open access: yes, 2020
Introducción: La fibrosis hepática afecta el pronóstico de los pacientes con esteatosis hepática no alcohólica. La diabetes mellitus tipo 2 es un factor de riesgo para fibrosis hepática avanzada en pacientes con esteatosis hepática no alcohólica ...
Malca Hernández, Joselito   +1 more
core  

Home - About - Disclaimer - Privacy